Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings

Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings

Background: To evaluate the weight loss outcomes of the large US cohort of patients undergoing endoscopic sleeve gastroplasty (ESG) with or without concomitant anti-obesity (AOM) use. Methods: We performed a retrospective analysis of adult patients who underwent ESG from seven different sites, from...

Full description

Bibliographic Details
Main Authors: Khushboo Gala, Wissam Ghusn, Vitor Brunaldi, Christopher McGowan, Reem Z. Sharaiha, Daniel Maselli, Brandon Vanderwel, Prashant Kedia, Michael Ujiki, Eric Wilson, Eric J. Vargas, Andrew C. Storm, Barham K. Abu Dayyeh
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Obesity Pillars
Subjects:
Endoscopic sleeve gastroplasty
Antiobesity medications
Obesity
Bariatric endoscopy
GLP-1 receptor agonists
Weight loss
Online Access:http://www.sciencedirect.com/science/article/pii/S2667368124000147

Internet

http://www.sciencedirect.com/science/article/pii/S2667368124000147

Similar Items